SELVAS Al

About SELVAS Al

SELVAS AI, established on March 31, 1999, as Diotech, is a publicly traded company on the KOSDAQ and a specialist in artificial intelligence solutions. The company, led by CEO Kwak Min-cheol, rebranded to SELVAS AI in 2016 to reflect its focus on AI and launched its integrated AI brand, "Selvy". This brand name combines "SEL" from the company name and "IVY" to signify scalability and self-sustaining growth.

The firm's operations are structured around three primary segments: AI-based technology, AI application solutions, and electronic dictionaries. The core AI technologies encompass voice intelligence (Selvy STT for speech-to-text, Selvy TTS for text-to-speech), handwriting intelligence (Selvy Pen), and image intelligence (Selvy OCR). These foundational technologies are leveraged to create applied solutions for various industries, including healthcare, automotive, education, and finance. Revenue is generated through the sale and licensing of these software solutions and products. For the twelve months ending March 31, 2025, the company reported revenue of 111.65B KRW.

In the healthcare sector, SELVAS AI offers "Selvy MediVoice," a medical voice recognition solution that streamlines the creation of medical records, and "Selvy Checkup," which predicts disease outbreak probabilities based on health screening data. A significant strategic move was the acquisition of a controlling stake in Mediana, a medical device manufacturer, integrating SELVAS AI's software with Mediana's hardware, such as patient monitoring devices and defibrillators, to advance in the MedTech market and telemedicine. Other key products include "Selvy Note" for transcribing meetings and interviews, "odiro" for AI-powered audio content creation, and "OnFit," a smart fitness center management solution. The company also continues to supply its electronic dictionary, "DioDict," to major clients like Samsung Electronics.